85 lines
		
	
	
		
			3.1 KiB
		
	
	
	
		
			Markdown
		
	
	
		
			Executable File
		
	
	
	
	
			
		
		
	
	
			85 lines
		
	
	
		
			3.1 KiB
		
	
	
	
		
			Markdown
		
	
	
		
			Executable File
		
	
	
	
	
# Legal FAQ — Free‑Tier Quota & AGPL Compliance
 | 
						||
 | 
						||
> **Operational behaviour (limits, counters, delays) is documented in  
 | 
						||
> [`33_333_QUOTA_OVERVIEW.md`](33_333_QUOTA_OVERVIEW.md).**  
 | 
						||
> This page covers only the legal aspects of offering Stella Ops as a
 | 
						||
> service or embedding it into another product while the free‑tier limits are
 | 
						||
> in place.
 | 
						||
 | 
						||
---
 | 
						||
 | 
						||
## 1 · Does enforcing a quota violate the AGPL?
 | 
						||
 | 
						||
**No.**  
 | 
						||
AGPL‑3.0 does not forbid implementing usage controls in the program itself.
 | 
						||
Recipients retain the freedoms to run, study, modify and share the software.
 | 
						||
The Stella Ops quota:
 | 
						||
 | 
						||
* Is enforced **solely at the service layer** (Redis counters) — the source
 | 
						||
  code implementing the quota is published under AGPL‑3.0‑or‑later.
 | 
						||
* Never disables functionality; it introduces *time delays* only after the
 | 
						||
  free allocation is exhausted.
 | 
						||
* Can be bypassed entirely by rebuilding from source and removing the
 | 
						||
  enforcement middleware — the licence explicitly allows such modifications.
 | 
						||
 | 
						||
Therefore the quota complies with §§ 0 & 2 of the AGPL.
 | 
						||
 | 
						||
---
 | 
						||
 | 
						||
## 2 · Can I redistribute Stella Ops with the quota removed?
 | 
						||
 | 
						||
Yes, provided you:
 | 
						||
 | 
						||
1. **Publish the full corresponding source code** of your modified version  
 | 
						||
   (AGPL § 13 & § 5c), and
 | 
						||
2. Clearly indicate the changes (AGPL § 5a).
 | 
						||
 | 
						||
You may *retain* or *relax* the limits, or introduce your own tiering, as long
 | 
						||
as the complete modified source is offered to every user of the service.
 | 
						||
 | 
						||
---
 | 
						||
 | 
						||
## 3 · Embedding in a proprietary appliance
 | 
						||
 | 
						||
You may ship Stella Ops inside a hardware or virtual appliance **only if** the
 | 
						||
entire combined work is distributed under **AGPL‑3.0‑or‑later** and you supply
 | 
						||
the full source code for both the scanner and your integration glue.
 | 
						||
 | 
						||
Shipping an AGPL component while keeping the rest closed‑source violates
 | 
						||
§ 13 (*“remote network interaction”*).
 | 
						||
 | 
						||
---
 | 
						||
 | 
						||
## 4 · SaaS redistribution
 | 
						||
 | 
						||
Operating a public SaaS that offers Stella Ops scans to third parties triggers
 | 
						||
the **network‑use clause**.  You must:
 | 
						||
 | 
						||
* Provide the complete, buildable source of **your running version** —
 | 
						||
  including quota patches or UI branding.
 | 
						||
* Present the offer **conspicuously** (e.g. a “Source Code” footer link).
 | 
						||
 | 
						||
Failure to do so breaches § 13 and can terminate your licence under § 8.
 | 
						||
 | 
						||
---
 | 
						||
 | 
						||
## 5 · Is e‑mail collection for the JWT legal?
 | 
						||
 | 
						||
* **Purpose limitation (GDPR Art. 5‑1 b):** address is used only to deliver the
 | 
						||
  JWT or optional release notes.
 | 
						||
* **Data minimisation (Art. 5‑1 c):** no name, IP or marketing preferences are
 | 
						||
  required; a blank e‑mail body suffices.
 | 
						||
* **Storage limitation (Art. 5‑1 e):** addresses are deleted or hashed after
 | 
						||
  ≤ 7 days unless the sender opts into updates.
 | 
						||
 | 
						||
Hence the token workflow adheres to GDPR principles.
 | 
						||
 | 
						||
---
 | 
						||
 | 
						||
## 6 · Change‑log
 | 
						||
 | 
						||
| Version | Date | Notes |
 | 
						||
|---------|------|-------|
 | 
						||
| **2.0** | 2025‑07‑16 | Removed runtime quota details; linked to new authoritative overview. |
 | 
						||
| 1.0 | 2024‑12‑20 | Initial legal FAQ. |
 |